Your browser doesn't support javascript.
loading
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.
Cheng, Hao D; Dowell, Karen G; Bailey-Kellogg, Chris; Goods, Brittany A; Love, J Christopher; Ferrari, Guido; Alter, Galit; Gach, Johannes; Forthal, Donald N; Lewis, George K; Greene, Kelli; Gao, Hongmei; Montefiori, David C; Ackerman, Margaret E.
Affiliation
  • Cheng HD; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.
  • Dowell KG; Molecular and Cellular Biology Program, Dartmouth College, 14 Engineering Dr., Hanover, NH, 03755, USA.
  • Bailey-Kellogg C; Department of Computer Science, Dartmouth College, Hanover, 03755, USA.
  • Goods BA; Department of Computer Science, Dartmouth College, Hanover, 03755, USA.
  • Love JC; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Ferrari G; Department of Biological Engineering, Koch Institute at MIT, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Alter G; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Gach J; Department of Biological Engineering, Koch Institute at MIT, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Forthal DN; Department of Surgery, Duke University Medical Center, Durham, NC, 27710, USA.
  • Lewis GK; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27719, USA.
  • Greene K; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
  • Gao H; Division of Infectious Diseases, Irvine School of Medicine, University California, Irvine, CA, 92697, USA.
  • Montefiori DC; Division of Infectious Diseases, Irvine School of Medicine, University California, Irvine, CA, 92697, USA.
  • Ackerman ME; Division of Vaccine Research, Institute of Human Virology, University Maryland School of Medicine, Baltimore, MD, 21201, USA.
Retrovirology ; 18(1): 35, 2021 10 30.
Article in En | MEDLINE | ID: mdl-34717659
ABSTRACT

BACKGROUND:

The critical role of antibody Fc-mediated effector functions in immune defense has been widely reported in various viral infections. These effector functions confer cellular responses through engagement with innate immune cells. The precise mechanism(s) by which immunoglobulin G (IgG) Fc domain and cognate receptors may afford protection are poorly understood, however, in the context of HIV/SHIV infections. Many different in vitro assays have been developed and utilized to measure effector functions, but the extent to which these assays capture distinct antibody activities has not been fully elucidated.

RESULTS:

In this study, six Fc-mediated effector function assays and two biophysical antibody profiling assays were performed on a common set of samples from HIV-1 infected and vaccinated subjects. Biophysical antibody profiles supported robust prediction of diverse IgG effector functions across distinct Fc-mediated effector function assays. While a number of assays showed correlated activities, supervised machine learning models indicated unique antibody features as primary contributing factors to the associated effector functions. Additional experiments established the mechanistic relevance of relationships discovered using this unbiased approach.

CONCLUSIONS:

In sum, this study provides better resolution on the diversity and complexity of effector function assays, offering a clearer perspective into this family of antibody mechanisms of action to inform future HIV-1 treatment and vaccination strategies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Immunoglobulin Fc Fragments / HIV Antibodies / HIV Infections / HIV-1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Retrovirology Journal subject: VIROLOGIA Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Immunoglobulin Fc Fragments / HIV Antibodies / HIV Infections / HIV-1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Retrovirology Journal subject: VIROLOGIA Year: 2021 Document type: Article Affiliation country: